Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Flying to the heart of the matter

02.04.2010
The first systematic map of heart failure identifies hundreds of genes that regulate heart function

Was it a horror film or a sci-fi spoof? Fans of the 1986 blockbuster "The Fly" have been debating the issue ever since but one point has always been accepted. The underlying idea is plainly too far-fetched to be plausible: man and flies have nothing at all in common and the idea that they could exchange genes is ridiculous.

Or is it? The cover story of the scientific journal Cell (April 2, 2010) is a paper in which scientists at the Institute of Molecular Biotechnology (IMBA) in Vienna, Austria, report that human hearts and fly hearts are essentially under the control of many of the same genes. Using a model of heart failure in the fly, they present a systematic map of the genes involved in heart disease and heart failure and confirm that one of the control mechanisms they have identified really is associated with heart failure in flies, mice and in man.

500 genes involved in regulation of heart function

Heart disease represents the most common cause of death in Europe and North America but our knowledge of its genetic causes remains scant. In close collaboration with Rolf Bodmer of the Sanford-Burnham Medical Research Institute in La Jolla, California, Greg Neely in Josef Penninger's group at the IMBA has screened for genes that regulate heart function in the fly. Taking advantage of the in-house fly library VDRC (Vienna Drosophila Research Center), he found nearly 500 genes that when inhibited caused increased mortality when the flies were stressed. Penninger's collaborators at Strand Life Sciences in Bangalore, India used advanced computer methods to investigate the interconnections between the genes and the result - which looks like a super-complicated version of a city transport system - is the first global map of the genetic interactions behind heart function and heart failure.

From fly to mouse to humans

As Penninger notes, "About 35% of the hits relate to genes that are already known to be involved in heart function, so the method works. But we wanted to see what the other genes do." One of the 'novel' pathways detected was the CCR4-Not complex. This is highly conserved through evolution but the idea that it has a role in the heart was new. Neely was able to confirm that it is involved in heart function in the fly, and Keiji Kuba at the Akita University School of Medicine Global COE in Japan, generated knockout mice for Not3 gene, one of the CCR4-Not components and found that the mice developed severe heart problems when subjected to cardiac stress. What does CCR4-Not do in man? Based on the results of the work in flies, it seemed possible that mutations (variants) around the site of the human NOT3 gene could be associated with heart disease.

Working with Andrew Hicks and Peter P. Pramstaller of the EURAC-Institute of Genetic Medicine in Bolzano, Italy, and Arne Pfeufer of the Institute of Human Genetics at Technical University in Munich, who are all part of the QTSCD consortium (QT Interval and Sudden Cardiac Death), to explore this possibility using human data from ECG recordings, this idea was shown to be correct: variants over the region are associated with changes in QT interval, which predispose to sudden cardiac death.

Penninger notes with satisfaction that "Our work on flies has identified a possible cause of human heart disease that the human genetic screens had missed."

Results may yield clues to future therapies

The result confirms that Neely's screen in flies can be used to identify genes involved in heart function and heart disease in mice and humans. The screen picked up very many genes, over a hundred of which have no known function. They may also represent candidates for factors that predispose individuals to heart disease. Investigating them will involve a vast amount of work that will be performed in collaboration with groups studying heart function in flies, zebra fish, mice and men. Combining data from all of these models will give an overall picture of heart function under normal and diseased conditions - and presumably important clues to new therapeutic possibilities.

The paper "A global in vivo Drosophila RNAi screen identifies NOT3 as a conserved regulator of heart function" by G. Gregory Neely et al. will be publish in the April 2, 2010 issue of the journal Cell, along with a cover illustration.

About IMBA
The IMBA - Institute for Molecular Biotechnology of the Austrian Academy of Sciences - opened in 2003. It combines fundamental and applied research in the field of biomedicine. Interdisciplinary research groups address functional genetic questions, particularly those related to the origin of disease. The ultimate goal is to implement acquired knowledge into the development of innovative applications for prevention, diagnosis and treatment of disease.
About IMP - IMBA Research Center
A cooperation contract links the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) to the Research Institute of Molecular Pathology (IMP), which has operated since 1988 and is supported by Boehringer Ingelheim. Under the name of the "IMP - IMBA Research Center", both institutes have access to a combined infrastructure in scientific and administrative areas. Together, the two institutes employ around 400 staff from 30 nations and are members of the Campus Vienna Biocenter.
Contact
Mag. Evelyn Missbach, MAS
IMP-IMBA Communications
Phone: +43 1 79730 3626
evelyn.missbach@imba.oeaw.ac.at
Scientific Contact:
Prof. Josef Penninger
josef.penninger@imba.oeaw.ac.at
Link to the Penninger Lab:
http://www.imba.oeaw.ac.at/research/josef-penninger/
Illustrations and a video are available at
http://www.imba.oeaw.ac.at/pressefoto-herzgene

Dr. Heidemarie Hurtl | idw
Further information:
http://www.imba.oeaw.ac.at/research/josef-penninger/
http://www.imba.oeaw.ac.at/pressefoto-herzgene

More articles from Life Sciences:

nachricht What the world's tiniest 'monster truck' reveals
23.08.2017 | American Chemical Society

nachricht Treating arthritis with algae
23.08.2017 | Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

What the world's tiniest 'monster truck' reveals

23.08.2017 | Life Sciences

Treating arthritis with algae

23.08.2017 | Life Sciences

Witnessing turbulent motion in the atmosphere of a distant star

23.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>